Target intelligence / Profile preview

Hepatocytes and other non-muscle cells

Molecular classification
Other (Cell Type)
01

Overview

Hepatocytes and other non-muscle cells refers to a broad category of cellular populations rather than a specific molecular target such as a receptor, enzyme, or transporter. Hepatocytes are the primary functional cells of the liver, responsible for critical physiological processes including the metabolism of carbohydrates, lipids, and proteins, as well as the detoxification of endogenous and exogenous substances (StatPearls, 2023). The term non-muscle cells is a general classification used in physiology to distinguish various cell types—such as adipocytes, hepatocytes, or fibroblasts—from skeletal, cardiac, or smooth muscle tissue, often in the context of metabolic regulation or insulin-mediated glucose disposal (Molecular Biology of the Cell, 2002). Because this entry describes a collection of cell types, it does not possess a single molecular classification or a unified mechanism of action. In a pharmacological context, these cells are frequently the site of drug metabolism (via Cytochrome P450 enzymes) or the intended destination for tissue-specific therapies, such as those targeting the asialoglycoprotein receptor on hepatocytes (LiverTox, 2020). However, treating a whole cell population as a target is considered a nomenclature error in molecular pharmacology, as therapeutic effects are mediated by specific proteins within these cells rather than the cells themselves (IUPHAR/BPS, 2024).

Other names
Liver cellsParenchymal cellsNon-myocytesHepatic cells
02

Mechanism of action

Not applicable. This entry refers to a cell population rather than a specific molecular target. Drugs interacting with these cells do so via specific receptors (e.g., Insulin receptor), enzymes (e.g., HMG-CoA reductase), or transporters (e.g., OATP1B1) expressed on or within the cells (IUPHAR/BPS, 2024).

03

Biological functions

MetabolismDetoxificationProtein synthesisBile productionGlucose homeostasis
04

Disease associations

HepatitisLiver cirrhosisHepatocellular carcinomaDrug-induced liver injury (DILI)Metabolic syndrome
05

Safety considerations

HepatotoxicityDrug-induced liver injuryOff-target effects in non-muscle tissuesSteatosisDrug-drug interactions via CYP450 enzymes
06

Interacting drugs

Acetaminophen

4 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)Alkaline phosphatase (ALP)BilirubinAlbuminProthrombin time

Beyond the preview

Go deeper on Hepatocytes and other non-muscle cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocytes and other non-muscle cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call